Metritrack Inc.

Metritrack Inc. is a medical device company specializing in automated breast ultrasound systems. The company develops the BVN™ (Breast Volume Navigator) Model G-2000, an FDA-cleared computer-assisted breast ultrasound solution designed to address the unmet clinical need of detecting breast cancers in women with dense breast tissue. The system employs proprietary dynamic mapping technology with anatomical referencing to achieve standardized, reproducible ultrasound exams with precision mapping of breast volume and small lesions within millimeters. Clinical evidence demonstrates that supplemental ultrasound combined with mammography doubles cancer detection rates in women with dense breasts, potentially detecting over 60,000 breast cancers annually that are missed by mammography alone. The BVN G-2000 is intended for use in imaging clinics, hospitals, and diagnostic centers serving the 18+ million women in the US with dense breast tissue. Metritrack partners with imaging facilities, sonographer training organizations, and clinical sites for system deployment and operator training. The company's focus is on improving breast cancer screening and detection outcomes through standardized, operator-independent imaging protocols.